Myeloproliferative neoplasms arise following the acquisition of gene mutations in haematopoietic stem cells (HSCs) that result in cytokine‐independent activation of Janus kinase‐signal transducer and activator of transcription (JAK‐STAT) signalling. The gene discussed is SOAT1; the disease is myeloproliferative neoplasm.